Calendar of Upcoming Events

This conference is designed to facilitate a comprehensive knowledge exchange of current and future PSMA PET imaging and radioligand therapies. The program aims to provide an in-depth view of these imaging and therapy approaches for medical oncologists, nuclear medicine physicians, urologists, radiologists, technologists, and advanced practice providers involved in the management of prostate cancer patients.

The annual AUA meeting provides unparalleled access to groundbreaking research, new guidelines, and the latest advances in urologic medicine.

The ASCO annual meeting provides opportunities to discover the latest high-impact science, multidisciplinary expertise, and evidence-based practice in genitourinary cancer care.

The SNMMI Annual Meeting is the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging.

The meeting theme is “Rediscovering Radiation Medicine and Exploring New Indications,” and planning is underway.

The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from all over the world. ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments, and a collaborative approach converge to shape the future of genitourinary cancer care.

LUGPA is a trade association that represents independent urology group practices in the U.S., with more than 2,200 physicians who make up more than 25% of the nation’s practicing urologists, and provide more than 30% of the total urologic care in the U.S. The association is committed to providing the best resources and information for its member practices through advocacy, research, data collection and benchmarking efforts.

This highly interactive meeting will feature discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists. State-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in urologic oncology, will be discussed.